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Development/Plasticity/Repair

Macrophage-Derived Vascular Endothelial Growth Factor-A
Is Integral to Neuromuscular Junction Reinnervation after
Nerve Injury
Chuieng-Yi Lu,1,2p Katherine B. Santosa,1,3p Albina Jablonka-Shariff,1 Bianca Vannucci,1 Anja Fuchs,4
Isaiah Turnbull,4 Deng Pan,1 Matthew D. Wood,1 and Alison K. Snyder-Warwick1
1

Division of Plastic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110-1093, 2Division of
Reconstructive Microsurgery, Department of Plastic Surgery, Chang Gung Memorial Hospital, Chang Gung University, Taoyuan City, Guishan
District 33305, Taiwan, 3Section of Plastic and Reconstructive Surgery, Department of Surgery, University of Michigan, Ann Arbor, Michigan
48109-4217, and 4Division of General Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110-1093

Functional recovery in the end target muscle is a determinant of outcome after peripheral nerve injury. The neuromuscular
junction (NMJ) provides the interface between nerve and muscle and includes non-myelinating terminal Schwann cells (tSCs).
After nerve injury, tSCs extend cytoplasmic processes between NMJs to guide axon growth and NMJ reinnervation. The mechanisms related to NMJ reinnervation are not known. We used multiple mouse models to investigate the mechanisms of NMJ
reinnervation in both sexes, specifically whether macrophage-derived vascular endothelial growth factor-A (Vegf-A) is crucial
to establishing NMJ reinnervation at the end target muscle. Both macrophage number and Vegf-A expression increased in
end target muscles after nerve injury and repair. In mice with impaired recruitment of macrophages and monocytes (Ccr22/2
mice), the absence of CD681 cells (macrophages) in the muscle resulted in diminished muscle function. Using a Vegf-receptor 2
(VegfR2) inhibitor (cabozantinib; CBZ) via oral gavage in wild-type (WT) mice resulted in reduced tSC cytoplasmic process extension and decreased NMJ reinnervation compared with saline controls. Mice with Vegf-A conditionally knocked out in macrophages
(Vegf-Afl/fl; LysMCre mice) demonstrated a more prolonged detrimental effect on NMJ reinnervation and worse functional muscle recovery. Together, these results show that contributions of the immune system are integral for NMJ reinnervation and functional
muscle recovery after nerve injury.
Key words: muscle recovery; nerve injury; neuromuscular junction; reinnervation; terminal Schwann cell; vascular endothelial growth factor

Significance Statement
This work demonstrates beneficial contributions of a macrophage-mediated response for neuromuscular junction (NMJ) reinnervation following nerve injury and repair. Macrophage recruitment occurred at the NMJ, distant from the nerve injury site,
to support functional recovery at the muscle. We have shown hindered terminal Schwann cell (tSC) injury response and NMJ
recovery with inhibition of: (1) macrophage recruitment after injury; (2) vascular endothelial growth factor receptor 2
(VegfR2) signaling; and (3) Vegf secretion from macrophages. We conclude that macrophage-derived Vegf is a key component
of NMJ recovery after injury. Determining the mechanisms active at the end target muscle after motor nerve injury reveals
new therapeutic targets that may translate to improve motor recovery following nerve injury.
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Figure 1. Increased leukocytes are present in the end target muscle following peripheral nerve injury in WT mice. A–C, Lymphocyte (CD451, arrows) cell numbers significantly increased
after nerve injury compared with naive, uninjured muscles and peaked at day 14. D–F, Macrophage (CD681, arrows) cell numbers were significantly higher than in naive muscles at all time
points from days 3 to 21 postinjury. G, Flow cytometry revealed peak cell numbers in lymphocytes and macrophages at days 3 and 14 after nerve injury. H, Gene expressions of the Ccr2
ligands, chemokine-ligand-2 (Ccl2) and chemokine-ligand-8 (Ccl8), were significantly higher at days 3 and 14, respectively, compared with naive muscles. Ccl8 remained elevated at day 21.
A, B, CD45 Ab = lymphocytes (green). D, E, CD68 Ab = macrophages (red), S100 Ab = glial cells (green), BTX = a-bungarotoxin (endplates, purple), DAPI = nuclear staining (blue). Scale
bars: 20 mm (A, B) and 50 mm (D, E). Data: mean 6 SD; N = 3–4 mice/time point; pp , 0.05.

Introduction
Peripheral nerve injuries are common and devastating, disproportionately affecting young, healthy people (Grinsell and
Keating, 2014). Although the peripheral nervous system is
unique from the central nervous system in that it has the capacity
to regenerate after injury, patient outcomes are often unsatisfactory (Novak et al., 2009; Ciaramitaro et al., 2010). Important
factors predicting recovery from nerve injury include injury severity, duration, and location; patient age and health; and management approach (Boyd et al., 2011; Novak et al., 2011).
Despite advancements in our understanding of the mechanisms
contributing to nerve regeneration, further investigation is warranted to improve clinical outcomes. Comprehensive study of
the entire system encompassing the neuronal cell body, axons,
neuromuscular junction (NMJ), and end target muscle is necessary to understand the mechanisms contributing to repair and
recovery.

Axonal regeneration across a nerve transection site has been
shown to be largely driven by immune-mediated mechanisms
(Cattin et al., 2015). Within hours of injury, calcium accumulation drives Wallerian degeneration resulting in axonal and myelin fragmentation distal to the injury site (Burnett and Zager,
2004; Faroni et al., 2015). Axonal debris leads to resident macrophage activation and circulating monocyte recruitment to the
nerve injury site (Lech and Anders, 2013). Monocytes differentiate into macrophages after migration. Different macrophage
phenotypes secrete factors integral to healing (Tomlinson et al.,
2018), including vascular endothelial growth factor (VEGF), a
key regulator of angiogenesis (Nissen et al., 1998; Stockmann et
al., 2011; Shvartsman et al., 2014). Angiogenesis results in newlyformed blood vessels lined with endothelial cells (ECs) that guide
myelinating Schwann cells (SCs), which then guide regenerating
axons across a nerve injury site. Induced myeloid cell depletion
has a net negative effect, compromising axonal regeneration and
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recovery of motor function, highlighting
the importance of myeloid cells to the
milieu supporting axonal regeneration
(Barrette et al., 2008).
While these cellular mechanisms contributing to axonal regeneration in the
nerve are well described, analogous mechanisms contributing to NMJ reinnervation
have not been reported. Functional outcome
after nerve injury is ultimately dependent
on successful target muscle reinnervation at
the NMJ. The NMJ represents the interface
of nerve and muscle and consists of three
main components: the nerve terminal,
which releases acetylcholine (ACh) vesicles
across the synaptic cleft, the postsynaptic
motor endplates, or ACh receptors (AChRs),
and one to three terminal SCs (tSCs; or
perisynaptic SCs) that encompass the
entire NMJ (Kang et al., 2003; Wilson and
Deschenes, 2005; Smith et al., 2013;
Santosa et al., 2018; Snyder-Warwick et
Figure 2. Ccr2 / mice have impaired macrophage recruitment to the NMJ. A, Flow cytometry showed a comparable
al., 2018). These non-myelinating tSCs
number of macrophages/muscle in naive, uninjured WT, and Ccr2 / mice. B–D, WT mice showed increased CD681
contribute to NMJ maintenance, signalmacrophages/image area (green, arrows) around the NMJ 5 d after nerve injury, while Ccr2 / mice had nearly no macing, and repair (Son and Thompson, 1995;
rophage presence at the NMJ 5 d after nerve injury. CD68 Ab = macrophages (green), BTX = a-bungarotoxin (endplates,
Kang et al., 2014). After nerve injury, tSCs
red), DAPI = nuclear staining (blue). Scale bar: 50 mm (C, D). Data: mean 6 SD; N = 3–4 mice/genotype/time point;
pp , 0.05.
extend long processes to facilitate axon
sprouting and guidance to the NMJ (Kang
et al., 2014), but the contributions of tSCs
Surgical procedure for sciatic nerve injury and repair
to NMJ recovery following nerve injury are not fully underAnimals were anesthetized to an appropriate level via intraperitoneal ketamine and dexmedetomidine cocktail (50 mg/kg). Buprenorphine-SR
stood. Specifically, interactions of tSCs with an immune
(1.0 mg/kg) and saline were administered for postoperative pain control
response to facilitate NMJ recovery have not been reported. In
and hydration, respectively. The sciatic nerve from the right hindlimb
this study, we demonstrate that an immune response occurs at
was sharply transected and an immediate epineurial repair was perthe NMJ following nerve transection and repair. Specifically, we
formed with microsutures under a standard operating microscope as
note an increase in macrophages and Vegf-A at the NMJ after
described previously (Vannucci et al., 2019). Animals were then placed
nerve injury. We show that inhibition of: (1) macrophage
on a heating pad, and anesthesia was reversed with Antisedan
recruitment; (2) Vegf-receptor 2 (VegfR2) signaling; and (3)
(0.5 mg/kg).
macrophage-derived Vegf-A secretion all result in diminished
tSC injury response and NMJ recovery.

Materials and Methods
Animals
All mice were housed in a central animal facility and were maintained
preoperatively and postoperatively in strict accordance with the National
Institutes of Health guidelines and according to protocols approved
by the institutional animal research ethics committee (IACUC) at
Washington University School of Medicine in St. Louis. For all experiments, adult (12- to 16-week-old) mice of both sexes were analyzed.
Wild-type (WT; pure C57BL/6 background) mice were bred in our
laboratory. Chemokine receptor 2 (Ccr2) constitutive knock-out mice,
Ccr2 / (Willenborg et al., 2012), kindly provided by Gwendolyn
Randolph (Washington University, St. Louis, MO), were used as a model
lacking the ability to recruit monocytes and macrophages to injury sites
and were bred in our lab. To generate a conditional knock-out of Vegf-A
specifically in macrophages, Vegf-Afl/fl; LysM Cre mice were crossed to
Vegf-Afl/fl mice (Gerber et al., 1999) and compared with Vegf-Afl/fl controls. Vegf-Afl/fl mice were generously provided by Matthew Silva
(Washington University, St. Louis) and LysMCre mice (Clausen et al., 1999),
in which the LysM gene drives Cre expression in macrophages, were kindly
provided by Roberta Faccio (Washington University, St. Louis) and
Benjamin Levi (University of Michigan). To assess VegfR2 (also known as
Flk-1), Flk-1Cre; Rosa 26 tdTomato mice were generous provided by David
Ornitz (Washington University, St. Louis; Motoike et al., 2003). Mutant
mice were genotyped by the TAG Center of Transnetyx.

Cabozantinib (CBZ) administration
To determine the effect of lack of VegfR2 signaling, CBZ (XL184,
MedChemExpress), a VegfR2 inhibitor (Yakes et al., 2011; Haider et al.,
2015), was diluted in saline and administered via oral gavage beginning
6 d after nerve injury and repair as muscle Vegf-A expression begins to
peak at 10 d postinjury and regenerating axons do not reach the NMJ
until about that same time. WT mice were randomized to receive either
100 mg/kg of CBZ (200 ml/d) or saline control (200 ml/d) for 7 d (days 6–
13 following nerve injury and repair). Mice were then killed 14, 21, and
28 d after nerve injury (n = 3 mice/treatment/time point).

Muscle harvest and immunocytochemistry
At the designated time points (3–42 d postinjury), mice were anesthetized with intraperitoneal ketamine cocktail and then killed. The tibialis
anterior (TA), extensor hallucis longus (EHL), and extensor digitorum
longus (EDL) muscles were harvested from the injured and uninjured
legs of the animal as described previously (Vannucci et al., 2019).
To evaluate macrophage markers (CD68), Vegf-A, and VegfR2 protein expression, muscles were fixed in 4% paraformaldehyde (PFA).
Frozen sections (25 mm thick) were immunostained as described previously (Snyder-Warwick et al., 2018). The primary antibodies used
include: mouse anti-VEGF-A (1:1200, Abcam catalog #ab1316, RRID:
AB_299738), mouse anti-VegfR2 (1:200, Cell Signaling Technology catalog #2479, RRID:AB_2212507), rat anti-CD68 (1:500, Bio-Rad catalog
#MCA1957, RRID:AB_322219), and rat anti-CD45 (1:100, BD Biosciences
catalog #550539, RRID:AB_2174426).
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Figure 3. Ccr2 / mice exhibit decreased NMJ reinnervation and diminished muscle function following nerve injury and
repair. A, B, WT and Ccr2 / mice have normal NMJ morphology and innervation (arrows) in naive, uninjured muscles.
C, D, NMJ reinnervation, represented by colocalization of neurofilament and motor endplate staining (arrows), was significantly decreased in Ccr2 / mice compared with WT mice at 14 d after nerve injury and repair. A significant difference in
innervation remained at 21 d (images not shown), but was mitigated by 28 d (E, F). G, Bar graph summarizes the quantitative findings according to full, partial, or no NMJ innervation (none). H, Evoked CMAPs of the TA muscle were significantly
lower in Ccr2 / mice compared with WT mice at 28 d after nerve injury and repair, despite no difference in reinnervation
at that time point. NF200 Ab = axons (green), BTX = a-bungarotoxin (endplates, red), DAPI = nuclear staining (blue). Scale
bar: 50 mm. Data: mean 6 SD; N = 3–6 mice/genotype/time point; pp , 0.05.

To evaluate axonal reinnervation and tSC process extensions, EHL
and EDL muscles fixed in 2% PFA were mounted on slides as previously
described (Jablonka-Shariff et al., 2019; Vannucci et al., 2019). Whole
mounted muscles were stained with rabbit anti-NF200 (1:400; SigmaAldrich catalog #N4142, RRID:AB_477272) or rabbit anti-S100 (1:10;
Agilent catalog #Z0311, RRID:AB_10013383) overnight at 4°C. Both
frozen sections and the whole mounts were incubated in secondary
antibodies Alexa Fluor 488 nm or Alexa Fluor 594 nm (1:1000; Life
Technologies). Tissues were further incubated with a-bungarotoxin
(aBTX) Alexa Fluor 555 (aBTX, 1:1000, Thermo Fisher Scientific catalog #B35451, RRID:AB_2617152) or Alexa Fluor 647 aBTX (1:1000).
aBTX binds specifically to AChRs in the postsynaptic membrane.
Muscles were mounted on glass slides using Vectashield mounting medium with DAPI (Vector Laboratories catalog #H-1200, RRID:AB_
2336790).

Morphometric evaluation
All muscles were imaged under 20 magnification with an Axio Imager M2 fluorescent
microscope (Zeiss). Images with a total area of
445.54  333.66 mm2 were analyzed using NIH
ImageJ (https://imagej.nih.gov/ij/), and figures
were prepared using Adobe Photoshop CC 2018
and Adobe Illustrator CC 2018 system (Adobe
Systems). For quantitative analyses, muscle sections from at least three animals per group were
processed, and at least five random sections,
totaling .100 NMJs were analyzed per muscle.
aBTX was used to stain AChRs, S100 antibody was used to label all SCs (myelinating
and non-myelinating), and NF200 antibody labeled neurofilament/axons. CD45 and CD68
were used to mark leukocytes and macrophages, respectively. The number of CD451
and CD681 cells were counted per field of
view. Vegf-A protein expression was calculated
as the percent of total area of the image analyzed. ImageJ macro was used to quantify
Vegf-A expression. The percentage of the area
in a standard field that was positive for Vegf-A
was measured by the software. Images used for
measurements were collected with similar microscopic settings for experimental and control
groups. For endplate reinnervation and tSC
process extensions, only the most superficial
muscle layers were evaluated as previously
described (Vannucci et al., 2019). NMJ reinnervation was defined as the colocalization of
the nerve terminal stained with NF200 and
AChRs stained with aBTX. NMJs were considered fully reinnervated if endplates were 75%
covered with NF200 staining. Partial NMJ
reinnervation was defined as colocalization of
BTX and NF200 staining, but with ,75% coverage. No reinnervation, or denervation was
defined as no NF200 staining present over
BTX. Presence of tSC processes was defined as
extension of the tSC cytoplasm branching outside the boundaries of the original motor end
plates. The percentage of NMJs with tSC processes was evaluated after staining with S100.
All evaluations were performed in a blinded
fashion by three independent investigators.

Functional muscle recovery assessments
Functional TA muscle recovery was assessed at
14, 21, and 28 d after nerve injury and repair,
before tissue harvest, using compound muscle
action potentials (CMAPs) using FASt System,
Red Rock Laboratories (Bogdanik et al., 2015;
Vannucci et al., 2019). After anesthesia was
induced, the sciatic nerve was exposed, and the
previous nerve repair site was identified. The stimulating electrode was
placed under the sciatic nerve at a location 10 mm proximal to the injury
site. Two receiving electrodes were placed transcutaneously into the TA
muscle belly, and the ground electrode was attached to a different part of
body. After stimulation at 50 Hz CMAPs amplitudes were recorded. For
comparison, CMAPs were also measured at the contralateral uninjured
side. The CMAPs with the maximal peak-to-peak peak amplitudes (in
mV) were calculated for every mouse (n = 2 or more mice per group per
time point).
Tissue processing for flow cytometry
To analyze the immune cell composition within muscle at days 3, 7, 14,
and 21 after nerve injury, muscles from the affected hindlimb were
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collected from WT and Ccr2 / mice for collagenase digestion and leukocyte isolation using
modifications of published procedures (Kuswanto
et al., 2016; Pan et al., 2019). Muscles used for analysis included the majority of muscles innervated
by sciatic nerve (TA, peroneus tertius, PL, PB, gastrocnemius, plantaris, soleus, tibialis posterior,
FHL, FDL, and popliteus). For each flow cytometric sample, muscles from two hind limbs, i.e.,
affected muscles from two mice, were pooled.
Muscles were minced, followed by digestion with
1 mg/ml Collagenase II and 10 mg/ml DNase I
(both from Sigma Aldrich) in RPMI 1640 media
containing 2% fetal calf serum, for 45 min at 37°C.
Remaining tissue pieces were then dissociated
through a 100-mm cell strainer, and the resulting
cell suspension was centrifuged at 500  g.
Immune cells were then enriched by Percoll gradient centrifugation, for which cells were resuspended in 40% Percoll, overlayed over 70% Percoll
(GE Healthcare), and centrifuged for 20 min at 850
 g at 4°C without brake. The interphase was then
washed with HBSS containing 10% calf serum, filtered through 70 mm, and resuspended in FACS
buffer (PBS with 2% calf serum and 0.01% NaN3).
Nucleated cell counts and cell viability were determined by diluting cell suspensions with a mixture
of acridine orange and propidium iodide and analyzing on a K2 Cellometer (Nexcelom).
Flow cytometry was performed using standard procedures (Fuchs et al., 2019). In short,
enriched immune cells were incubated with
TruStain FcX (anti-mouse CD16/32, Biolegend)
to block Fc receptors for 10 min on ice, before
staining with fluorochrome-conjugated antibodies. Antibodies used were purchased from BD
Figure 4. Vegf-A expression increases in the end target muscle following nerve injury in WT mice. A, Immunostaining
Bioscience: CD45-BV510 (clone 30-F11), Siglec
of Vegf-A protein (pseudocolored in gray, arrows) was nearly undetectable in naive, uninjured muscles. B–D, From the 3rd
F-PE/CF594 (E50-2440), CD64-PE (X54-5/
to the 12th day postinjury, Vegf-A expression steadily increased. E, The increasing Vegf-A protein expression/image area
7.1.1); from Biolegend: CD11b-PerCP-Cy5.5
under 20 magnification was quantitatively summarized for all time points. Vegf-A Ab (gray). Scale bar: 50 mm. Data:
(M1/70), Ly6C-BV421 (HK1.4), Ly6G-Alexa
mean 6 SD; N= 3 mice/time point; pp , 0.05.
Fluor 700 (1A8), and from R&D Systems:
MerTK-biotin (polyclonal). MerTK-biotin was
included. RNA was extracted from at least 2 animals per group in the
detected with PE/Cy7-conjugated streptavidin
different models of the study.
(BD Biosciences). Dead cells were excluded by staining with fixable live/
Quantitative real-time PCR (qRT-PCR) was performed using
dead dye (Zombie NIR, Biolegend). Samples were acquired on an LSR
TaqMan Fast Universal PCR Master mix and specific TaqMan PCR priFortessa equipped with four lasers (488, 405, 640, and 552 nm) using
mers-probes combination were purchased from Applied Biosystems.
the Diva software (all from BD Biosciences), and data were analyzed
Vegf-A (Mm00437306-m1) and Gapdh (Mm99999915-g1) Taq-Man
with FlowJo 10 (Treestar Inc.). Macrophages were identified as CD451
CD11b1 CD641 MerTK1; monocytes were gated as CD451 CD11b1
Gene Expression Assays were used. All qPCR studies were performed on
Ly6C1 Ly6G– CD64– Siglec F– SSClow-med. Cell concentrations in
a Step One Plus instrument (Applied Biosystems), and results were anastained samples were determined by adding counting beads to the
lyzed using Microsoft Excel and DDCt method (Livak and Schmittgen,
samples immediately before flow cytometric acquisition (123count
2001). Relative expression levels were calculated for the Vegf-A gene by
eBeads, eBioscience). Cell concentrations in samples were calculated
normalizing first to Gapdh level and then to the expression in sham
per manufacturer’s directions and were used to determine the cell
uninjured muscle for each mouse genotype. Relative gene expression for
counts in muscle from two hind limbs.
muscle on the injured side is shown as fold change compared with the
uninjured side. Samples were run in triplicate, and “non-template conRNA extraction and quantitative PCR
trols” with water and no RT enzyme were conducted as negative controls.
TA muscles were dissected and immediately placed in RNALater solution (Thermo Fisher Scientific), homogenized in TRIzol (Invitrogen),
Statistical analysis
and stored at 80°C. Total extracted RNA was treated with RNase-free
Continuous variables were reported as mean 6 SD, while categorical
DNase (QIAGEN). The RNA pellet was further purified using
variables were reported in percentages. Quantification of reinnervation
RNeasy MinElute Cleanup kit (QIAGEN) according to the manufacand tSC process extension were performed in a blinded fashion with
turer’s protocols and quantified with a NanoDrop ND-1000 spectrothree independent evaluators, with three mice used per experimental
photometer. Sample quality was evaluated with the 260 nm/280 nm
group in every time point. Two-tailed, unpaired Student’s t tests were
ratio. Complementary DNA was synthesized from total RNA
used to assess statistical differences between continuous variable data(100 mg) using High-Capacity cDNA Transverse Transcription kit
sets, while x 2 tests were used for categorical variables. Statistical signifi(Applied Biosystems). Samples without reverse transcriptase (RT)
cance was set at p , 0.05. Statistical analyses were performed using
GraphPad Prism 8 (GraphPad Software).
enzyme, to control for genomic DNA contamination, were also
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p = 0.0009; Fig. 1H). The peaks in cytokine
expression levels at 3 and 14 d postinjury
correlate with peaks in monocyte and macrophage numbers within those same time
points.
The Ccr22/2 mouse exhibits decreased
NMJ reinnervation and diminished
muscle function following nerve injury
and repair
Given the robust immune response within
the muscle of the WT mice following nerve
injury, we further assessed the role of macrophages at the NMJ following nerve injury
in the Ccr2 / mouse, which lacks a
major mechanism of monocyte and macrophage recruitment. Macrophage numbers
did not differ at baseline between WT and
Ccr2 / mice (Fig. 2). Ccr2 / mice
were confirmed to have significantly
(p , 0.000001) diminished macrophage
recruitment to the NMJ after injury, however (Fig. 2). Ccr2 / mice demonstrated
overall normal NMJ morphology in naive
muscle compared with WT mice (Fig. 3A,
B), and performance on a walking grid test
did not differ from uninjured WT mice
(Wood MD, unpublished data). After
nerve transection and repair, NMJ reinnervation was significantly decreased in
Figure 5. VegfR2 is expressed in tSC cytoplasm and processes connecting cell bodies after nerve injury. In order to deterCcr2 / mice compared with controls at
mine VegfR2 localization, we used Flk-1Cre; Rosa26tdTomato mice, where Rosa26TdTomato staining (red) is present at locations
14 and 21 d postinjury (Fig. 3). Sigof VegfR2 (Flk-1) expression. A, In naive muscles without previous nerve injury, VegfR2 was located on ECs (white arrows)
nificantly less partial (p , 0.0052) and
but not in tSCs or around NMJs. B, At day 6 after nerve injury and repair, the NMJ with tSCs was surrounded by VegfR2significantly more denervation (none, p ,
expressing ECs (white arrow). C, D, At higher magnifications, VegfR2 localized within tSC cell bodies and cytoplasmic proc0.0043) were noted at 14 d postinjury in
esses (yellow arrows) in addition to ECs. The single channel insets, pseudocolored in gray, highlight the positive staining of
the Ccr2 / mice compared with WT and
VegfR2 within the tSCs and tSC processes (yellow arrows). E, F, Colocalization of S100 staining (glia) with anti-Flk1 is seen
21 d after injury (p , 0.0276 for partial,
at tSCs at 6 d postinjury. The inset (E) represents a single red channel pseudocolored in gray showing the positive staining
p , 0.0005 for none). Quantitative differof VegfR2 in tSCs. Immunostaining for BTX (endplates, yellow stars) in panels A–D are shown as insets pseudocolored in
ences in NMJ reinnervation mitigated by
gray. These single-channel images represent BTX staining of the area shown in color. Flk-1 = VegfR2 (red), S100 Ab = glial
cells (green), DAPI = nuclear staining (blue). N = 3 mice/time point. Scale bars: 50 mm (A, B) and 20 mm (C, D).
28 d postinjury in all categories of innervation (Fig. 3G). In addition to morphologic
reinnervation differences, Ccr2 / mice
exhibited diminished muscle function comResults
pared with WT mice at 28 d after nerve
An immune response occurs at the NMJ in the end target
injury
and
repair.
CMAP
amplitudes were significantly lower (p =
muscle following nerve injury
0.035)
for
Ccr2
/
mice
(9.17
6 1.3 mV) compared with WT mice
After sciatic nerve transection and repair, increased leukocytes
(10.91
6
1.1
mV),
despite
equivalent
reinnervation at this time
(CD451) and macrophages (CD681) were found in the EDL
point (Fig. 3H).
muscles from WT mice within the first two weeks after nerve
injury and repair (Fig. 1A–G). Both leukocyte and macrophage
(defined as CD45, CD11b, CD64, and MerTK positivity) cell
numbers peaked within the first 14 d after nerve injury and
repair via whole muscle flow cytometry (Fig. 1G), although significant differences were noted only at day 3: macrophages day 3
versus naive, p , 0.00502; monocytes day 3 versus naive, p ,
0.0035; lymphocytes day 3 versus naive, p , 0.0466. Quantitative analysis of immunostaining showed persistently elevated
CD451 and CD681 cell numbers near the NMJ from days 3 to
21 after nerve injury and repair. Increased mRNA expression of
the Ccr2 receptor ligands, chemokine-ligand-2 (Ccl2; at 3 d after
nerve injury) and chemokine-ligand-8 (Ccl8; at 14 d after nerve
injury), were significantly higher than naive muscles (Ccl2 vs naive
at 3 d: p , 0.0304; Ccl8 vs naive at 14 d: p = 0.0004, 21 d:

Vegf-A expression increases in the end target muscle after
nerve injury
A critical role of macrophages after nerve injury is promoting
formation of blood vessels that guide SCs to migrate across nerve
gaps and mediate axonal regeneration (Cattin et al., 2015).
Macrophages secrete Vegf-A, which promotes angiogenesis (Fantin
et al., 2010) and may also recruit more macrophages from the
blood stream (Cursiefen et al., 2004). Given the association of
Vegf-A with macrophages, we hypothesized its presence in
muscle is strongly correlated with NMJ reinnervation after
nerve injury. Nearly undetectable Vegf-A protein levels were
observed in muscles that were uninjured and following 1 d after
nerve injury. By the third day postinjury, Vegf-A expression
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Figure 6. VegfR2 inhibition decreases Vegf-A expression and macrophage cell numbers after nerve injury. A, CBZ, a VegfR2 inhibitor, treatment (daily from days 6 to 13 following nerve injury) decreased Vegf-A protein expression at 14 d after nerve injury compared with saline-gavaged control mice. B, In control mice, Vegf-A mRNA expression
was elevated by 14 d postinjury, peaked at 21 d, and returned to baseline by 28 d. CBZ inhibited Vegf-A mRNA expression at days 14 and 21 postinjury, but the effect was
not sustained by day 28. C–E, CBZ resulted in significantly decreased macrophage numbers at all time points. Arrows point to CD681 cells (pseudocolored in gray in C, D).
a-Bungarotoxin staining of (BTX purple) demonstrates relationship of macrophages near NMJs. F–H, The percent of macrophages (green) colocalizing (arrows) with Vegf-A
(red) was significantly less in the CBZ-treated group than saline-treated controls at day 14. The magnified images of single cells in F’, G’ highlight the colocalization of VegfA with a macrophages via isolated color channels. Vegf-A Ab (red), CD68 Ab = macrophages (green), BTX = a-bungarotoxin (endplates, purple), DAPI = nuclear staining
(blue). Scale bar: 20 mm. Data: mean 6 SD; N = 3–5 mice/treatment/time point; pp , 0.05.

increased significantly (p = 0.0157) compared with uninjured
muscles, and peaked at day 14 (p , 0.001; Fig. 4).
VegfR2 inhibition results in fewer Vegf-A-secreting
macrophages at the NMJ
Given the increased Vegf-A expression in the end target muscle
following nerve injury, we investigated VegfR2 expression and
signaling. VegfR2 localization was performed using the Flk1Cre;
TdTomato mouse, which exhibits Rosa staining at locations of
VegfR2 (Sierra-Filardi et al., 2014). VegfR2 was noted within
ECs of the blood vessels, tSCs, and nerve terminals at 6 d after nerve injury and repair (Fig. 5). We also investigated the
impact of VegfR2 signaling inhibition with the VegfR2 inhibitor, CBZ. To determine the presence of a feedback loop for
inhibition of VEGFR2 signaling, we evaluated VEGF-A levels, macrophages (CD681 cells), and CD681, Vegf-A1 cells.
CBZ administration to WT mice resulted in immediate,

temporarily decreased Vegf-A protein expression in the
muscles after nerve injury compared with saline-gavaged
mice at 14 d (CBZ = 1.63, saline = 3.33, p , 0.001; Fig. 6A).
Vegf-A mRNA expression levels were lower in the muscle of
the nerve-injured hindlimb relative to the uninjured side in
the CBZ group compared with controls at both 14 d (CBZ =
1.65, saline = 2.37, p , 0.001) and 21 d (CBZ = 1.73, saline =
3.89, p , 0.001; Fig. 6B). Macrophage (CD681 cells) numbers were significantly lower in the CBZ mice across all time
points (Fig. 6C–E). Co-staining of Vegf-A with CD68 (Fig.
6F,G,F’,G’) revealed a significantly lower percentage of VegfA1, CD681 cells in the CBZ group at 14 d (CBZ = 63.46%,
saline = 85.52%, p = 0.004), indicating the presence of fewer
Vegf-A-secreting macrophages (Fig. 6F–H). The number
of cells co-staining with Vegf-A and CD68 were similar
between CBZ-treated mice and controls at 21 d (p = 0.67),
reflecting the transient effect of the CBZ treatment. Vegf-A
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standard deviations were noted in some
groups. There were no differences in reinnervation between the CBZ and control
groups at 21 or 28 d (Fig. 8), reflecting the
temporary effects of CBZ. Electrophysiological testing by CMAP showed no significant differences between the two groups
at all time points (Fig. 8H). The results
show that Vegf-A in the muscle is intricately correlated with tSC function and
NMJ reinnervation, but not muscle
function.
Vegf-Afl/fl; LysMCre mice have a lower
percentage of Vegf-A-secreting
macrophages near the NMJ following
nerve injury and repair
VegfR2 inhibitor, CBZ, has limited bioavailability, short bioactivity, and non-specificity. To better assess the impact of Vegf-A
on reinnervation, then, we used a transgenic model with conditional knock-out of
Vegf-A specifically in macrophages using
Vegf-Afl/fl; LysMCre mice. Vegf-Afl/fl mice
were used as controls for comparison.
Vegf-A protein expression in the muscles
of Vegf-Afl/fl; LysMCre mice was significantly
decreased at 14 d (p , 0.001) and 21 d
(p = 0.011) after nerve injury (Fig. 9A).
Vegf-A gene expression via qPCR in TA
muscles showed incremental increases
from 7 to 28 d after nerve injury in control
mice, whereas significantly (p = 0.011)
Figure 7. VegfR2/Vegf-A inhibition reduces tSC process extension beyond NMJ area after nerve injury. A, B, tSC cytolower levels of Vegf-A mRNA expression
plasmic processes in the CBZ-treated mice (yellow arrows) were absent, short, or fragmented, and extended from fewer
were seen in the TA muscles of Vegf-Afl/fl;
NMJs at day 14 compared with long tSC processes in saline-treated control mice (white arrows). The insets highlight long
LysMCre mice at 7, 14, and 28 d postinjury
tSC processes (white arrow) in saline-treated mice (A) and lack of processes (yellow arrow) in CBZ-treated mice (B). C, D,
This effect did not persist on day 21 postinjury and repair (8 d after the last dose of CBZ), as there was no difference
compared with control mice. In Vegf-Afl/fl;
between CBZ-treated mice and controls relative to percent NMJs with tSC processes. E, Quantitatively, the percentage of
LysMCre mice, muscle Vegf-A mRNA levels
NMJs with tSC processes in CBZ-treated mice was half that of controls at 14 d and not significantly different from controls
peaked at 21 d after nerve injury and then
at 21 d. S100Ab = glial cells (green), BTX = a-bungarotoxin (endplates, red), DAPI = nuclear staining (blue). Scale
again decreased by 28 d (Fig. 9B). Unlike the
bar: 50 mm. Data: mean 6 SD; N = 3–5 mice/treatment/time point; pp , 0.05.
CBZ model, CD681 macrophage counts
near the NMJ after nerve injury in Vegf-Afl/fl;
mRNA and the percentage of CD681, Vegf-A1 cells
LysMCre mice were either higher (days 7 and
increased in CBZ treated mice at 28 d, reflecting the transient
28, p , 0.05) or comparable (days 14 and 21) to control mice (Fig.
nature of the inhibitor and a return to baseline values.
9C–G). Co-staining of Vegf-A with CD68 in the muscles (Fig. 9H)
revealed a significantly lower percentage of CD681 cells expressing
VegfR2 (Flk-1) inhibition reduces tSC cytoplasmic process
Vegf-A in the Vegf-Afl/fl; LysMCre mice at all time points, as expected
extension and NMJ reinnervation
in this model. Vegf expression seen in the Vegf-Afl/fl; LysMCre mice
We hypothesized that Vegf-A supports NMJ reinnervation by
is contributed by ECs within blood vessels and inefficiency of the
guiding tSC process extension after nerve injury. tSC process
conditional mutation, as a small number of macrophages continue
extension was significantly (p , 0.05) decreased in the CBZ
to express Vegf-A.
group (11%) at 14 d, as compared with the saline control group
(22%; Fig. 7). At 21 d, the difference was no longer significant,
Vegf-Afl/fl; LysMCre mice have fewer tSC processes,
which we suspect is related to the temporary effects of the drug.
diminished NMJ reinnervation, and poor functional recovery
Morphologically, the tSC processes were shorter in length (Fig.
following nerve injury and repair
7B) in the CBZ group at 14 d after nerve injury but at 21 d the
Evaluation of tSC process extension showed significantly fewer
tSCs were still able to form processes (Fig. 7D). NMJ reinnervaprocesses in Vegf-Afl/fl; LysMCre mice compared with controls at
tion was significantly decreased in the CBZ group compared
all time points up to 21 d after nerve repair (Fig. 10). By 28 d, tSC
with controls at 14 d postinjury when partial and full innervation
process extensions were observed in the Vegf-Afl/fl; LysMCre mice
were grouped together (CBZ 18.7%, saline 34.1%, p = 0.048), but
(Fig. 10H), while the control mice showed less tSC communicadid not significantly differ in the three categories of full (CBZ
tion between motor end plates, indicating potential withdrawal
3.1%, saline 10.2%, p , 0.29), partial (CBZ 15.6%, saline 24.0%,
of the tSC processes after successful reinnervation (Fig. 10G).
Full NMJ reinnervation was significantly less in the Vegf-Afl/fl;
p , 0.28), and none (CBZ 81.3%, saline 65.9%, p , 0.20) as large
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LysMCre mice at 21 d (control 62.13%,
Vegf-Afl/fl; LysMCre 28.30%, p , 0.0036).
Denervation (none) was significantly
higher in the the Vegf-Afl/fl; LysMCre mice
at 21 d compared with controls (control
19.2%, Vegf-Afl/fl; LysMCre 58.8%, p ,
0.0272). By 28 d after nerve repair, when
tSC process extension continued to increase in Vegf-Afl/fl; LysMCre mice, full NMJ
reinnervation was nearly 80% in both
groups (Fig. 11). Despite equivalence of
morphologic reinnervation data at 28 d,
Vegf-Afl/fl; LysMCre mice demonstrated significantly poorer CMAP performance at
this time point compared with control
mice (p = 0.0065), indicating a not only a
morphologic difference, but also functional
impact from macrophage-derived Vegf-A
deletion in the setting of nerve injury and
NMJ reinnervation.

Discussion
The immune response is important for
axonal regeneration at the nerve transection site (Cattin et al., 2015). In this study,
we show an immune response also occurs
in muscle and is integral to NMJ reinnervation following nerve injury. We first
showed an inflammatory response downstream from the injury, including monocyte and macrophage recruitment to the
target muscle and increased Ccl2 and
Ccl8 expression, responsible for attracting
monocytes from bloodstream to target
muscle. The Ccr2 /
mouse model
(impaired macrophage recruitment) showed
monocytes and macrophages are important
for NMJ reinnervation and end target musFigure 8. VegfR2/Vegf-A inhibition reduces NMJ reinnervation after nerve injury. A, B, NMJ reinnervation,
cle function after nerve injury. Impaired
defined as overlap of axonal staining (NF200 Ab, green) with a-bungarotoxin (BTX, endplates, red) staining
macrophage recruitment resulted in delayed
(arrows), was significantly less in CBZ-treated mice compared with controls at day 14, but not at days 21 (C,
NMJ reinnervation and diminished muscle
D) or 28 (E, F) after nerve injury and repair. The insets highlight innervated endplate (A) and denervated endfunction, even after NMJ reinnervation,
plate (B) in saline-treated and CBZ-treated mice, respectively. G, Quantification analyses showed both full and
demonstrating innervation is not equivalent
partial NMJ reinnervation in CBZ-treated mice were approximately half the values of controls at 14 d postinto synaptic function. We showed Vegf-A
jury. The percentage of fully reinnervated NMJs did not change from 21 to 28 d postinjury in the CBZ group. H,
expression within muscle increased from
There were no differences in CMAP amplitudes between CBZ-treated mice and saline-treated controls at all
3 d after nerve injury and repair, suggesting
time points postinjury. DAPI = nuclear staining (blue). Scale bar: 50 mm. Data: mean 6 SD; N = 3–5 mice/
neurons are not the source of Vegf-A. Vegftreatment/time point.
A levels are not elevated in uninjured WT
mice and increase before regenerating axons
reach the NMJ. Disruption of Vegf-A sigVegfR2 (or Flk-1), the receptor responsible for initiating
naling with VegfR2 inhibitor, CBZ, or using
downstream Vegf-A pathways, is found in ECs, initiates angioa transgenic mouse model lacking macrophage-secreted Vegf-A,
genesis, and increases vessel permeability (Olsson et al., 2006). In
resulted in fewer tSC cytoplasmic processes (which normally
the nervous system, VegfR2 is expressed in neuronal cells (Krum
extend after denervating injuries), decreased NMJ reinnervaand Rosenstein, 1998; Park et al., 2016), SCs (Sondell et al.,
tion, and diminished muscle function. These findings are note1999a,b), and ECs involved in posttraumatic or developmental
worthy as diminished or delayed NMJ reinnervation should
angiogenesis (Krum and Rosenstein, 1998; Rosenstein et al.,
result in increased tSC process extension. In summary, we have
1998). Interestingly, most studies focusing on VegfR2 effects have
shown NMJ reinnervation hindrance with inhibition of the folbeen conducted on CNS tissue or cells. In the PNS, exogenous
lowing: (1) macrophage recruitment; (2) VegfR2 signaling; and
Vegf-A has neurotrophic actions which can trigger neurite exten(3) Vegf-A secretion from macrophages. We conclude that
sion and promote axonal outgrowth in cultured ganglia cells
macrophage-secreted Vegf-A is a key component of NMJ re(Sondell et al., 1999b). In an in vivo model, nerve allografts
pretreated with Vegf-A showed enhanced SC growth and
covery after injury.
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exists in both myelinating SCs within nerve and
non-myelinating tSCs at the NMJ (Fig. 5).
These data suggest Vegf-A signaling induces
SCs to extend cytoplasmic processes to guide
the incoming regenerating axons at both the
nerve injury site (Gomez-Sanchez et al., 2017)
and the NMJ (Santosa et al., 2018). In the transgenic mouse, macrophage-derived Vegf-A is
diminished at all time points when tSC processes are decreased compared with controls
(Figs. 9, 10). Furthermore, increased Flk-1/
VegfR2 intensity in ECs around the NMJ combined with higher Vegf-A expression levels
highlight the potential for increased vessel permeability, allowing additional immune cell
recruitment. Given the trophic role Vegf-A
plays in neurogenesis and angiogenesis in the
developing or posttraumatic nervous system
(Rosenstein et al., 2010; Shvartsman et al.,
2014), our results strongly indicate that Vegf-A
is integral to tSC morphologic changes during
NMJ reinnervation. The relationship of tSC
processes and angiogenesis requires additional
investigation. Interestingly, we showed Vegf-A
signaling inhibition via different mechanisms
resulted in decreased tSC cytoplasmic process
extension over a delayed time course; tSC
process extension is necessary for NMJ reinnervation. tSC processes normally extend
beginning 3 d after nerve transection and diminish as NMJ reinnervation occurs or
over four weeks (O’Malley et al., 1999).
Since denervation would stimulate tSC process formation (Reynolds and Woolf, 1992;
Son and Thompson, 1995; Rosenstein et al.,
1998; Koirala et al., 2000; Kang et al., 2014),
and we observed less tSC process extension,
these data suggest Vegf-A signaling changes
are directly linked to tSC process formation.
Figure 9. Vegf-A expression within macrophages is decreased in Vegf-Afl/fl; LysMCre mice. A, Vegf-A protein expresAs tSC processes guide axons to the NMJ
sion was significantly decreased in Vegf-Afl/fl; LysMCre mice at days 14 and 21 following nerve injury and repair. Vegf-A
(Reynolds
and Woolf, 1992; Kang et al., 2003,
levels peaked in both conditional knock-out mice and controls (Vegf-Afl/fl) at 21 d postinjury. B, Vegf-A mRNA expres2014), altered tSC function likely contributed
fl/fl
Cre
sion was significantly decreased in Vegf-A ; LysM mice compared with the control mice. Vegf-A mRNA expression
to decreased NMJ reinnervation, resulting in
peaked at day 21 in the Vegf-Afl/fl; LysMCre mice before significantly decreasing again at 28 d after nerve injury. C–H,
diminished muscle function in the absence
fl/fl
Cre
Macrophage (green) number was higher in the Vegf-A ; LysM mice compared with controls at days 7 and 28 after
fl/fl
Cre
of Vegf-A signaling. Our data show tSCs
nerve injury but did not differ between Vegf-A ; LysM mice and controls at days 14 and 21. Both groups had fewer
respond to immune environment alterations
macrophages present in the muscle at day 28. G, The percentage of CD681 cells (green) colocalizing with Vegf-A
and highlight the importance of tSC-macro(red, white arrows in C–F), however, was significantly decreased in Vegf-Afl/fl; LysMCre mice compared with controls at
phage (and macrophage-secreted Vegf-A)
all time points. Macrophages not colocalized with Vegf-A are indicated by yellow arrows. Vegf-A Ab (red), CD68 Ab =
macrophages (green), DAPI = nuclear staining (blue). Scale bar: 20 mm. Data: mean 6 SD; N = 3 mice/genotype/
interactions and tSC-nerve terminal interactime point; pp , 0.05.
tions. tSCs are key NMJ regulators contributing to NMJ signaling (Jahromi et al., 1992;
Reist and Smith, 1992; Corfas et al., 2004),
maintenance (Reddy et al., 2003; Barik et al.,
neovascularization, and VegfR2 was identified in SCs within nerve
2016), and repair (Smith et al., 2013; Ko and Robitaille, 2015; Lee
allograft (Sondell et al., 1999a). Raimondo et al. (2019) injected alet al., 2016). tSCs aid NMJ reinnervation by expressing Ccl2 to
ginate hydrogels secreting Vegf-A and insulin-like growth factor 1
recruit circulating monocytes (Fischer et al., 2008). tSCs, then,
directly into the target muscle following nerve injury and showed
may both initiate and interact with the cellular responses at the
improved functional reinnervation, citing an increased neuroNMJ after injury. Myelinating SCs are a target of macrophage
transmitter or postsynaptic response. Similarly, exogenous alginate
signaling; macrophages regulate SC differentiation and maturation
gel Vegf-A delivery to ischemic muscle after nerve crush demonfollowing nerve injury (Stratton et al., 2018). At the NMJ, tSCs are
strated beneficial NMJ recovery effects: delayed Wallerian degensimilarly key interactors with macrophage-secreted Vegf-A.
eration, AChR protection, and nerve growth factor-derived
The finding of an immune response downstream from the
and glial-derived nerve growth factor-dependent angiogenesis
nerve injury site, within the end target muscle, is novel. While
(Shvartsman et al., 2014). Our study shows that Flk-1/VegfR2
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we conclude that tSCs interact with the
immune response at the NMJ, the mechanisms triggering inflammation there
require further elucidation. Our results
contribute to literature regarding the importance of the inflammatory response
distant from the nerve injury. After optic
nerve injury, downstream inflammatory
events, including increased CD681 cells,
have been described (Tonari et al., 2012).
Furthermore, unilateral optic nerve injury
leads to microglial inflammatory responses
in both the ipsilateral and contralateral
retinas (Sobrado-Calvo et al., 2007). Macrophages may impact tSCs at the NMJ in our
sciatic nerve transection model similarly to
microglial cells at the retina in an optic
nerve injury model. The presence of inflammatory effects downstream from the injury
site may have translational therapeutic
implications. Elicitation of the NMJ injury
response mechanisms are essential to our
understanding of motor recovery following
nerve injury and may have importance for
other organ systems as well.
Our data support previous reports
outlining benefits of inflammation for
recovery in multiple injury types. Macrophages, for example, are important for
cutaneous wound healing via promotion
of inflammation and angiogenesis; alterations in macrophage phenotype influence
chronic wound formation (Koh and
DiPietro, 2011). Similarly, impaired
monocyte recruitment from the bloodstream in Ccr2-deficient mice resulted in
impaired cutaneous wound healing that
corrected with WT monocyte and macrophage transfer (Boniakowski et al., 2018).
The importance of macrophage-driven
inflammation, including VEGF release,
for recovery has also been established in
models of liver injury (You et al., 2013),
as well as muscle (Arnold et al., 2007;
Shireman et al., 2007) and bone
(Alexander et al., 2011; Schlundt et al.,
2018) healing. In nerve, axonal regeneration across a transection injury follows
Figure 10. tSC process extension is diminished after nerve injury in Vegf-Afl/fl; LysMCre mice. A, At day 7 after nerve injury,
the process of macrophage Vegf-A secretSCs extended their processes (arrow) in control mice. In contrast, tSC process extension was absent (arrow) at the NMJs in
tion, followed by angiogenesis, SC migraVegf-Afl/fl; LysMCre mice (B). Significant differences in tSC process extension persisted at days 14 (C, D) and 21 (E, F) postintion across ECs, and finally axonal
jury. The inset in panel E shows an NMJ with a long tSC process (arrow) in control mice. The inset in panel F shows two endregeneration along SC tubes (Jablonkaplates in Vegf-Afl/fl; LysMCre mice but only one (arrow) with a very short tSC process. By day 28, however, thinner tSC
Shariff et al., 2019). Inflammation,
processes were present in the NMJs of Vegf-Afl/fl; LysMCre mice (H) than in controls (G). I, Significant differences in the percent
although a commonly targeted pathoof NMJs with tSC process extension was most evident from days 7 to 21. S100 Ab = glial cells (green), BTX = a-bungarophysiological process, can be beneficial.
toxin (endplates, red), DAPI = nuclear staining (blue). Scale bar: 50 mm. Data: mean 6 SD; N = 3 mice/genotype/time point;
pp , 0.05.
The immune system’s contributions to
healing are complex and multi-phased.
Neutrophils are the first (24 h) immune
as Ccr2, a promiscuous receptor that responds to a variety of sigcells to respond after injury. Although
nals, including Ccl2 and Ccl8 (Sondell et al., 1999a; Willenborg
they contribute to healing by phagocytosis of debris, they are not
et al., 2012; Jablonka-Shariff et al., 2019). Once in tissue,
essential (Martin and Leibovich, 2005). Infiltrating monocytes
recruited monocytes differentiate into inflammatory phenotype
are recruited to the injury site within 48–96 h via receptors such
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Figure 11. Innervation and functional NMJ recovery in Vegf-Afl/fl; LysMCre mice is persistently worse than controls. NMJ reinnervation, as seen by the colocalization of the neurofilaments
(green) with motor endplates (red, arrows), is shown at days 14 (A, B), 21 (C, D), and 28 (E, F) postinjury and nerve repair. G, NMJ reinnervation was significantly worse in the Vegf-Afl/fl;
LysMCre mice, achieving only half of the reinnervation rate of controls, at day 21. Vegf-Afl/fl; LysMCre mice showed a significantly lower percentage of fully innervated NMJs and higher percentage
of denervated (none) NMJs compared with controls. By day 28, both groups of mice were able to reach nearly 80% of motor endplates fully innervated. H, Vegf-Afl/fl; LysMCre mice demonstrated
significantly poorer CMAP performance at 21 and 28 d postinjury compared with control mice, indicating a functional impact extending beyond morphologic differences. NF200 Ab = axons
(green), BTX = a-bungarotoxin (endplates, red), DAPI = nuclear staining (blue). Scale bar: 50 mm. Data: mean 6 SD; N = 3–5 mice/genotype/time point; pp , 0.05.
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from poor sensitivity of CMAP testing early in reinnervation.
As mice have incomplete NMJ reinnervation normally at
two weeks after nerve cut and repair, differences between
groups cannot be elucidated from low CMAP values. In addition, we have previously found that CMAP corresponds to
complete and not partial NMJ reinnervation (Vannucci et al.,
2019). Additional work is necessary to determine the signaling mechanisms at the NMJ following injury.
In conclusion, this study demonstrates multiple key findings
regarding target muscle functional recovery after nerve injury.
An inflammatory response occurs at the muscle, distant from the
site of nerve transection. Macrophages are integral for NMJ reinnervation after injury. Vegf-A signaling is necessary for tSC process extension, timely NMJ reinnervation, and muscle function
after reinnervation. Thus, macrophage-secreted Vegf-A is integral for NMJ recovery at the end target muscle after nerve injury.
Our proposed mechanisms occurring at the NMJ are summarized in Figure 12. Circulating monocytes are recruited into muscle via Ccl2–Ccr2 interactions. Macrophages then secrete VegfA, which may act on tSCs, facilitating tSC process extension to
induce axonal sprouting and guide axons to the NMJs. Vegf-A
also induces angiogenesis, allowing delivery of additional circulating cells and guidance of tSC processes, and may also interact
with nerve terminals. Additional investigation is warranted to
further elucidate the details of these cellular processes at the NMJ
following nerve injury.
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